# An Open-label Study of KW-3357

> **NCT01384903** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 221 (actual)

## Conditions studied

- Disseminated Intravascular Coagulation (DIC)

## Interventions

- **DRUG:** KW-3357
- **DRUG:** Plasma-derived antithrombin

## Key facts

- **NCT ID:** NCT01384903
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2017-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01384903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01384903, "An Open-label Study of KW-3357". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01384903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*